New Pharmaceutical Strategy for Europe – your input is requested!

Stella Kyriakides, European Commission commissioner for Health and Food Safety recently announced that “the Pharmaceutical Strategy for Europe is a cornerstone of our policy in the area of health for the next five years, and this is the chance for all stakeholders to help us shape it. “

Europe’s pharmaceutical sector is a major contributor to the EU economy in terms of creation of highly skilled jobs and investment in innovation, and now members of the public, healthcare professionals and providers, academia, researchers and the pharmaceutical industry are invited to contribute by completing an online questionnaire which will help guide the new Pharmaceutical Strategy for Europe

Coming in the wake of the COVID-19 pandemic, the strategy will also inform the newly proposed EU4Health Programme and align with Horizon Europe to create a “future proof” system which reaps the benefits of digitalisation and promotes innovation, especially in areas of unmet needs such as antimicrobials, medicines for children and medicines for rare diseases.

Find out more, and complete the questionnaire here.

Additional News

  • 16 April 2026

    Expanding Beyond FDA & EMA: Strengthening Our Global Regulatory Footprint with GCC

    Quinta-Analytica has successfully completed a full on-site GCP inspection within the GCC framework, further strengthening its international regulatory footprint and clinical research credibility.

  • 25 March 2026

    ADC Webinar: DAR, Bioanalysis and Intact MS in Next-Generation ADC Development

    On behalf of Conscio Group, registration is now open for our free expert-led webinar on DAR characterization, bioanalytical strategy and mass spectrometry insight in ADC development.

  • 17 December 2025

    PF 2026: Thank You from Quinta-Analytica

    In 2025, Quinta-Analytica continued to turn complex development challenges into tangible progress. Our PF 2026 message looks back at key milestones and thanks the partners, clients, and teams who made them possible.